EntryIndia LogoEntryIndia

Bharat Biotech pact to commercialise Covid vaccine Covaxin in US

Updated Feb 04, 2021 06:14 am

  • Bharat Biotech’s Covid-19 vaccine Covaxin would soon be available in the US market after the firm announced a tie-up with biopharmaceutical company Ocugen to commercialise it for US.Ocugen, a Nasdaq-listed firm, focuses on developing and commercialising gene therapies to cure blindness diseases.
  • It will have the US rights to the vaccine candidate and will be responsible for clinical development, regulatory approval (including EUA) and commercialisation for the US market.
Read More..

Tags: Bharat biotech commercialisation covaxin